Home › Ewing Sarcoma › Connecticut
Ewing Sarcoma clinical trials in Connecticut
4 studies for Ewing Sarcoma are looking for participants at sites in Connecticut.
Cities in Connecticut
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Connecticut Children's Medical Center, Hartford
RecruitingPhase 1
Ages 1 and older · All sexes · Updated Sep 25, 2026 · NCT07194044Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Yale New Haven Hospital ( Site 1012), New Haven
RecruitingPhase 1/2
6 Months – 25 Years · All sexes · Updated Sep 17, 2026 · NCT06395103Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Connecticut Children's Hospital, Hartford
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Sep 3, 2026 · NCT06541262Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Connecticut Children's Hospital, Hartford
RecruitingPhase 1/2
Up to age 26 · All sexes · Updated Sep 3, 2026 · NCT06465199From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.